You just read:

Bausch Health and Clearside Biomedical Announce Publication of PIVOTAL Phase 3 Data ON XIPERETM (triamcinolone acetonide suprachoroidal injectable suspension) in Ophthalmology

News provided by

Bausch Health Companies Inc.; Clearside Biomedical, Inc.

Jan 28, 2020, 07:00 ET